FDA Inspection 912077 — Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd
The FDA completed an inspection of Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd on Jan 22, 2015 in Huzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 22, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huzhou (China)